檢索結果 - G. Stoter

Refine Results
  1. 1
    Stenting in malignant vena caval obstruction

    Stenting in malignant vena caval obstruction 由 Matthijs Oudkerk, F. M. J. Heystraten, G. Stoter

    出版 1993
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development

    Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development 由 CJH Gerrits, M. de Jonge, JHM Schellens, G. Stoter, Jaap Verweij

    出版 1997
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines

    Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines 由 Henry Burger, Kees Nooter, AWM Boersma, Christine J. Kortland, G. Stoter

    出版 1998
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Lack of correlation between cisplatin-induced apoptosis,p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines

    Lack of correlation between cisplatin-induced apoptosis,p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines 由 Herman Burger, Kees Nooter, Antonius W.M. Boersma, Christine J. Kortland, G. Stoter

    出版 1997
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.

    Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR... 由 R J van de Griend, R. L. H. Bolhuis, G. Stoter, Robert C. Roozemond

    出版 1987
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection

    Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection 由 Peter de Bruijn, Jaap Verweij, Walter J. Loos, Kees Nooter, G. Stoter, Alex Sparreboom

    出版 1997
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy

    Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours follo... 由 Ronald de Wit, A C de Boer, Gabriele Linden, G. Stoter, Alex Sparreboom, Jaap Verweij

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients

    Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients 由 Ronald de Wit, WHJ Kruit, G. Stoter, Maaike de Boer, Joseph Kerger, Jaco J. Verweij

    出版 1998
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)

    Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere) 由 P.H.E. Hilkens, Jaap Verweij, C. J. Vecht, G. Stoter, Martin J. van den Bent

    出版 1997
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations

    Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations 由 Ron H.J. Mathijssen, Jaap Verweij, Maja J.A. de Jonge, Kees Nooter, G. Stoter, Alex Sparreboom

    出版 2002
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance

    A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance 由 Jaap Verweij, Hans Herweijer, R. Oosterom, MEL van der Burg, A.S.T. Planting, Caroline Seynaeve, G. Stoter, Kees Nooter

    出版 1991
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

    Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists 由 M de Boer-Dennert, Ronald de Wit, PIM Schmitz, J. Djontono, V van Beurden, G. Stoter, Jaap Verweij

    出版 1997
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

    Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump 由 Herman Burger, Hans van Tol, Antonius W.M. Boersma, Mariël Brok, Erik A.C. Wiemer, G. Stoter, Kees Nooter

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study

    Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study 由 SH Goey, A.M.M. Eggermont, CJA Punt, Rob Slingerland, JW Gratama, R. Oosterom, R. Oskam, RLH Bolhuis, G. Stoter

    出版 1995
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group

    Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Coop... 由 Ronald de Wit, G. Stoter, DTh Sleijfer, J.P. Neijt, W.W. ten Bokkel Huinink, Linda de Prijck, Laurence Collette, Richard Sylvester

    出版 1998
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMA

    COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMA 由 G. Stoter, D.Th. Sleijfer, C. P. J. Vendrik, H. Schraffordt Koops, A Struyvenberg, A.T. van Oosterom, Th. M. Brouwers, Herbert M. Pinedo

    出版 1979
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

    Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours 由 JHM Schellens, Jun Ma, A.S.T. Planting, MEL van der Burg, E. van Meerten, M de Boer-Dennert, PIM Schmitz, G. Stoter, Jaap Verweij

    出版 1996
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer

    Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer 由 M.E.L. van der Burg, Ronald de Wit, Wim L.J. van Putten, A. Logmans, Wim H.J. Kruit, G. Stoter, Jaap Verweij

    出版 2002
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group

    Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tra... 由 R. de Wit, G. Stoter, Dirk Th. Sleijfer, Stuart Kaye, PHM de Mulder, W. ten Bokkel Huinink, P Spaander, M de Pauw, Richard Sylvester

    出版 1995
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience

    Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience 由 C. B. H. W. Lamers, Stefan Sleijfer, Arnold G. Vulto, Wim H.J. Kruit, Mike Kliffen, Reno Debets, Jan W. Gratama, G. Stoter, Egbert Oosterwijk

    出版 2006
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:

檢索工具: